THE 4 DEMONS OF ATOPIC DERMATITIS OR AD OR ECZEMA Trademark
Trademark Overview
On Thursday, June 19, 2025, a trademark application was filed for THE 4 DEMONS OF ATOPIC DERMATITIS OR AD OR ECZEMA with the United States Patent and Trademark Office. The USPTO has given the THE 4 DEMONS OF ATOPIC DERMATITIS OR AD OR ECZEMA trademark a serial number of 99242631. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, July 7, 2026. This trademark is owned by Alphyn Biologics, Inc.. The THE 4 DEMONS OF ATOPIC DERMATITIS OR AD OR ECZEMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Research and development of drugs and medicines for the treatment of infections and skin diseases; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on infections and skin diseases; Pharmaceutical products testing, analysis, research, and development.
General Information
| Serial Number | 99242631 |
| Word Mark | THE 4 DEMONS OF ATOPIC DERMATITIS OR AD OR ECZEMA |
| Filing Date | Thursday, June 19, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, July 7, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 28, 2026 |
Trademark Statements
| Goods and Services | Research and development of drugs and medicines for the treatment of infections and skin diseases; Research and development in the pharmaceutical, life sciences, and biomedicine fields; Scientific research, testing, and analysis in the fields of pharmaceuticals, life science, and biomedicine; Medical and scientific research on infections and skin diseases; Pharmaceutical products testing, analysis, research, and development. |
| Pseudo Mark | THE FOUR DEMONS OF ATOPIC DERMATITIS OR AD OR ECZEMA |
| NOT AVAILABLE | Atopic Dermatitis, AD, Eczema |
| Pseudo Mark | THE FOR DEMONS OF ATOPIC DERMATITIS OR AD OR ECZEMA |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 19, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Alphyn Biologics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Annapolis, MD 21403
US |
Trademark Events
| Event Date | Event Description |
| Thursday, June 19, 2025 | NEW APPLICATION ENTERED |
| Thursday, June 19, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, October 27, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, November 6, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, March 24, 2026 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 24, 2026 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 24, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 23, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 23, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 23, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, June 27, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
